OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
000551$17.0958

Create Technology & Science Co Ltd

Industrial Machinery & EquipmentVerified

Create Technology & Science Co Ltd maintains a market capitalization of CNY 8.28 billion and a price-to-earnings ratio of 28.08, indicating a relatively high valuation compared to earnings. The company's price-to-book ratio of 2.85 suggests that the market values the company at a premium to its book value, while the debt-to-equity ratio of 0.14 indicates a conservative capital structure with limited leverage. The company's liquidity position is characterized by a current ratio of 1.89, which is above 1, suggesting it can cover its short-term liabilities with its short-term assets. In terms of profitability, the company's return on equity (ROE) of 10.15% and return on assets (ROA) of 4.59% are key indicators of its efficiency in generating returns for shareholders and asset utilization, respectively. The gross profit margin of 26.0% (CNY 1.096 billion gross profit on CNY 4.221 billion revenue) and operating margin of 11.7% (CNY 494.57 million operating income) suggest the company is effectively managing its production and operating costs. The company's revenue is concentrated in the industrial machinery and equipment segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as demand fluctuations in the industrial goods market. Looking ahead, the company is expected to grow its revenue to CNY 4.54 billion in the current fiscal year, representing a year-over-year increase of approximately 7.5%. The operating cash flow of CNY 621.73 million and free cash flow of CNY 307.76 million indicate the company is generating sufficient cash to support operations and potentially fund growth initiatives. The company's risk profile is characterized by a medium liquidity risk and low dilution risk. However, the risk assessment notes that net cash is negative after subtracting total debt, which could signal potential liquidity constraints if cash flow generation does not meet expectations. The company's capital expenditure of CNY -183.25 million suggests it is investing in its operations, which could support future growth. Recent analyst estimates indicate a mean recommendation of 2.00, with one "buy" rating and no "strong buy" or "sell" ratings, suggesting a generally positive outlook from the analyst community. The mean EPS estimate of CNY 0.76 and mean revenue estimate of CNY 4.54 billion provide a benchmark for the company's expected performance.

30-day price · 000551(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCreate Technology & Science Co Ltd
Ticker000551.SZ
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. Create Technology & Science Co Ltd is engaged in the design, development, and manufacturing of industrial machinery and equipment, primarily serving the industrial goods sector.

Classification. The company is classified under the Industrials economic sector, Industrial Goods business sector, and Industrial Machinery & Equipment industry, with a classification confidence of 0.92.

Create Technology & Science Co Ltd maintains a market capitalization of CNY 8.28 billion and a price-to-earnings ratio of 28.08, indicating a relatively high valuation compared to earnings. The company's price-to-book ratio of 2.85 suggests that the market values the company at a premium to its book value, while the debt-to-equity ratio of 0.14 indicates a conservative capital structure with limited leverage. The company's liquidity position is characterized by a current ratio of 1.89, which is above 1, suggesting it can cover its short-term liabilities with its short-term assets. In terms of profitability, the company's return on equity (ROE) of 10.15% and return on assets (ROA) of 4.59% are key indicators of its efficiency in generating returns for shareholders and asset utilization, respectively. The gross profit margin of 26.0% (CNY 1.096 billion gross profit on CNY 4.221 billion revenue) and operating margin of 11.7% (CNY 494.57 million operating income) suggest the company is effectively managing its production and operating costs. The company's revenue is concentrated in the industrial machinery and equipment segment, with no disclosed geographic diversification in the provided data. This concentration may expose the company to sector-specific risks, such as demand fluctuations in the industrial goods market. Looking ahead, the company is expected to grow its revenue to CNY 4.54 billion in the current fiscal year, representing a year-over-year increase of approximately 7.5%. The operating cash flow of CNY 621.73 million and free cash flow of CNY 307.76 million indicate the company is generating sufficient cash to support operations and potentially fund growth initiatives. The company's risk profile is characterized by a medium liquidity risk and low dilution risk. However, the risk assessment notes that net cash is negative after subtracting total debt, which could signal potential liquidity constraints if cash flow generation does not meet expectations. The company's capital expenditure of CNY -183.25 million suggests it is investing in its operations, which could support future growth. Recent analyst estimates indicate a mean recommendation of 2.00, with one "buy" rating and no "strong buy" or "sell" ratings, suggesting a generally positive outlook from the analyst community. The mean EPS estimate of CNY 0.76 and mean revenue estimate of CNY 4.54 billion provide a benchmark for the company's expected performance.
Key takeaways
  • The company has a conservative capital structure with a low debt-to-equity ratio of 0.14.
  • It generates a strong gross profit margin of 26.0% and operating margin of 11.7%.
  • The company's market valuation is relatively high, with a price-to-earnings ratio of 28.08.
  • Analysts have a generally positive outlook, with one "buy" rating and no "sell" ratings.
  • The company is expected to grow its revenue by approximately 7.5% in the current fiscal year.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$4.22B
Gross profit$1.10B
Operating income$494.6M
Net income$295.0M
R&D
SG&A
D&A
SBC
Operating cash flow$621.7M
CapEx-$183.3M
Free cash flow$307.8M
Total assets$6.42B
Total liabilities$3.52B
Total equity$2.90B
Cash & equivalents
Long-term debt$413.5M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$4.22B$494.6M$295.0M$307.8M
FY-1$4.19B$418.2M$250.6M$334.2M
FY-2$4.32B$294.6M$155.3M$152.8M
FY-3$4.18B$290.0M$163.9M$294.9M
FY-4$3.70B$213.1M$109.3M$121.8M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$6.42B$2.90B
FY-1$6.21B$2.62B
FY-2$6.16B$2.34B
FY-3$6.30B$2.30B
FY-4$5.45B$2.00B
PeriodOCFCapExFCFSBC
FY0$621.7M-$183.3M$307.8M
FY-1$464.3M-$111.5M$334.2M
FY-2$219.2M-$76.1M$152.8M
FY-3$428.6M-$61.8M$294.9M
FY-4$269.3M-$113.7M$121.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.22B$187.6M$124.2M
FQ-1$1.10B$114.4M$76.5M
FQ-2$1.04B$109.1M$57.3M
FQ-3$899.5M$136.0M$81.8M
FQ-4$1.18B$135.3M$79.5M
FQ-5$835.6M$51.8M$39.0M
FQ-6$1.10B$124.2M$66.6M
FQ-7$1.08B$132.3M$82.6M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$6.52B$3.05B$1.63B
FQ-1$6.42B$2.90B
FQ-2$6.16B$2.81B$1.28B
FQ-3$6.23B$2.82B
FQ-4$6.06B$2.69B$1.27B
FQ-5$6.21B$2.62B
FQ-6$6.31B$2.53B$1.10B
FQ-7$6.14B$2.43B
PeriodOCFCapExFCFSBC
FQ0$147.2M-$25.3M
FQ-1$621.7M-$183.3M
FQ-2$323.6M-$146.6M
FQ-3$176.1M-$104.0M
FQ-4$54.2M-$40.1M
FQ-5$464.3M-$111.5M
FQ-6$254.2M-$64.4M
FQ-7$76.0M-$42.8M
Valuation
Market price$17.09
Market cap$8.28B
Enterprise value$8.70B
P/E28.1
Reported non-GAAP P/E
EV/Revenue2.1
EV/Op income17.6
EV/OCF14.0
P/B2.9
P/Tangible book2.9
Tangible book$2.90B
Net cash-$413.5M
Current ratio1.9
Debt/Equity0.1
ROA4.6%
ROE10.2%
Cash conversion2.1%
CapEx/Revenue-4.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
Metric000551Activity
Op margin11.7%9.4% medp25 9.4% · p75 9.4%top quartile
Net margin7.0%5.8% medp25 5.8% · p75 5.8%top quartile
Gross margin26.0%26.9% medp25 26.9% · p75 26.9%bottom quartile
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-4.3%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity14.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.76 CNY
Mean revenue estimate4,540,000,000 CNY
Mean EBIT estimate604,000,000 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-17 02:49 UTCJob: 6a0c0c18